tirzepatide side effects vision loss Cancer: Evidence and Safety Data Wegovy Vision Loss Lawsuit [2026

The FDA approved tirzepatide under the brand name Zepbound for chronic weight management in adults with obesity or overweight with at least one weight-related condition, alongside a reduced-calorie diet and increased physical activity

The side effects cluster during dose increases and fade once you stabilize

For instance, eating smaller portions of sugary snacks or processed carbs can still stack up and undo the appetite control the medication provides

In pooled clinical trial data, injection site reactions occurred in 4.6% of tirzepatide-treated patients who developed anti-tirzepatide antibodies, compared to only 0.7% of those who did not develop antibodies

The markers associated with cardiometabolic risk were also improved in the older subgroup without obesity

Also, in many cases, tirzepatide injections are more affordable than semaglutide